Sorafenib in platinum-treated patients with extensive stage small cell lung cancer: a Southwest Oncology Group (SWOG 0435) phase II trial. [electronic resource]
Producer: 20110217Description: 1835-40 p. digitalISSN:- 1556-1380
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- therapeutic use
- Benzenesulfonates -- therapeutic use
- Drug Resistance, Neoplasm -- drug effects
- Female
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- diagnosis
- Neoplasm Staging
- Niacinamide -- analogs & derivatives
- Organoplatinum Compounds -- therapeutic use
- Phenylurea Compounds
- Pyridines -- therapeutic use
- Remission Induction
- Salvage Therapy
- Small Cell Lung Carcinoma -- drug therapy
- Sorafenib
- Survival Rate
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.